Effect of Food on Pharmacokinetics of MY008211A Tablets in Healthy Adult Subjects
Status:
Completed
Trial end date:
2022-10-23
Target enrollment:
Participant gender:
Summary
This was a single-center, single-dose, open-label clinical study. 12 subjects were randomly
assigned in a 1:1 ratio to one of the following dosing sequences (sequence 1: AB; Sequence 2:
BA). Each dosing sequence consisted of two cycles, one dose per cycle, with a 5-day washout
period between doses.